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Sprint training reduces urinary purine loss
following intense exercise in humans
Christos G. Stathis, Michael F. Carey, Alan Hayes, Andrew P. Garnham, and
Rodney J. Snow
Abstract: The influence of sprint training on endogenous urinary purine loss was examined in 7 active male subjects (age,
23.1 ± 1.8 y; body mass, 76.1 ± 3.1 kg; VO2 peak, 56.3 ± 4.0 mLkg–1min–1). Each subject performed a 30 s sprint perform-
ance test (PT), before and after 7 d of sprint training. Training consisted of 15 sprints, each lasting 10 s, on an air-braked
cycle ergometer performed twice each day. A rest period of 50 s separated each sprint during training. Sprint training re-
sulted in a 20% higher muscle ATP immediately after PT, a lower IMP (57% and 89%, immediately after and 10 min after
PT, respectively), and inosine accumulation (53% and 56%, immediately after and 10 min after the PT, respectively).
Sprint training also attenuated the exercise-induced increases in plasma inosine, hypoxanthine (Hx), and uric acid during
the first 120 min of recovery and reduced the total urinary excretion of purines (inosine + Hx + uric acid) in the 24 h re-
covery period following intense exercise. These results show that intermittent sprint training reduces the total urinary pu-
rine excretion after a 30 s sprint bout.
Key words: sprint training, inosine, hypoxanthine, uric acid, metabolism.
Re´sume´ : Dans cette e´tude, nous analysons les effets de l’entraıˆnement au sprint sur la perte urinaire de purines endoge`nes
chez sept hommes physiquement actifs (aˆge: 23,1 ± 1,8 ans, masse: 76,1 ± 3,1 kg, VO2 peak pointe: 56,3 ± 4,0 mLkg-1min-1).
Chaque sujet participe a` une e´preuve de sprint (PT) d’une dure´e de 30 s avant et apre`s un programme d’entraıˆnement
au sprint d’une dure´e de sept jours. Le programme d’entraıˆnement consiste en quinze sprints d’une dure´e de 10 s sur
un ergocycle a` re´sistance ae´rodynamique a` raison de deux fois par jour ; on alloue un repos d’une dure´e de 50 s en-
tre chaque sprint. Imme´diatement apre`s la fin du programme d’entraıˆnement, on enregistre une augmentation de 20 %
de la concentration musculaire d’ATP, une plus faible concentration d’inositol-monophosphate (imme´diatement apre`s
PT et 10 min plus tard : 57 % et 89 % respectivement de la valeur initiale) et une accumulation d’inosine imme´dia-
tement apre`s PT et 10 min plus tard : 53 % et 56 % respectivement de la valeur initiale. Le programme d’entraıˆ-
nement au sprint re´duit aussi l’augmentation de la concentration plasmatique d’inosine induite par l’effort, de la
concentration d’hypoxanthine (Hx) et d’acide urique au cours des 120 premie`res minutes de la re´cupe´ration. On ob-
serve e´galement une diminution de la quantite´ totale d’excre´tion urinaire de purines (inosine + Hx + acide urique) au
cours des 24 h suivant l’effort intense. En conclusion, un programme d’entraıˆnement intermittent au sprint re´duit la
quantite´ totale de purines excre´te´es dans l’urine apre`s un sprint d’une dure´e de 30 s.
Mots cle´s : entraıˆnement au sprint, inosine, hypoxanthine, acide urique, me´tabolisme.
[Traduit par la Re´daction]
Introduction
The ATP content of untrained human skeletal muscle is
about 20–25 mmolkg–1 dry mass (d.m.), and several reports
have demonstrated that intense intermittent sprint training
can lower the resting content by as much as 20% (Hellsten-
Westing et al. 1993a; Stathis et al. 1994; Hellsten et al.
2004). The factors responsible for the set point of resting
muscle adenine nucleotide (AdN = ATP + ADP + AMP)
content are unknown; however, it is influenced by the bal-
ance between loss of purine base from the muscle and its
production via de novo purine synthesis. Intense exercise re-
sults in a transient reduction of ATP and concomitant accu-
mulation of IMP (Stathis et al. 1994). Most of this IMP is
rapidly resynthesised to ATP during recovery, although a
small portion is further degraded and results in the produc-
tion of the purine bases inosine and hypoxanthine (Hx;
Stathis et al. 1994). Purine bases, not recovered intramuscu-
larly via purine salvage, efflux the muscle (Hellsten et al.
1999) and accumulate in the plasma (Bangsbo et al. 1992;
Tullson et al. 1995; Stathis et al. 1999). Once in the plasma,
purine bases are not recovered by skeletal muscle (Hellsten
et al. 1999). The magnitude of purine loss can be between
5% and 9% of the resting muscle ATP content (Bangsbo et
al. 1992; Hellsten et al. 1999). It has been reported that the
plasma purines are excreted in the urine (Nasrallah and Al
Khalidi 1964; Sutton et al. 1980; Stathis et al. 1999), or con-
verted to uric acid (Hellsten-Westing et al. 1994) and subse-
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quently excreted (Nasrallah and Al Khalidi 1964; Sorensen
and Levinson 1975; Stathis et al. 1999). Sorensen and Levin-
son (1975) demonstrated that, in a resting individual, the uric
acid loss via the gut is one third, whereas via the urine it is two
thirds of the total uric acid loss of an untrained individual.
Exercise intensity and duration can influence the plasma pu-
rine accumulation in recovery (Sjodin and Hellsten-Westing
1990; Hellsten et al. 1999), as does the frequency and num-
ber of intermittent sprint bouts (Balsom et al. 1992a; Balsom
et al. 1992b; Stathis et al. 1999). The number of repetitions
in a sprint challenge also influences the excretion of urinary
purines during recovery (Stathis et al. 1999).
Sprint training reduces the accumulation of IMP (Stathis
et al. 1994; Harmer et al. 2000; Parra et al. 2000) and ino-
sine (Stathis et al. 1994) in the muscle following an intense
sprint. Furthermore, sprint training attenuates the plasma in-
osine, Hx, and uric acid accumulation during recovery from
an intense exercise bout (Stathis et al. 1994). However, the
effect of sprint training on urinary purine excretion follow-
ing a maximal sprint bout is unknown.
The aim of this study was to investigate the effects of an
intense 7 d sprint training program on the loss of endoge-
nous purine metabolites in the urine during recovery from
an intense sprint bout. It was hypothesized that sprint train-
ing will reduce the accumulation of muscle IMP and inosine
during a 30 s sprint bout and attenuate the concentration of
plasma purine metabolites, i.e., inosine, Hx, and uric acid,
during recovery from a 30 s sprint bout, consistent with pre-
vious studies. This will lead to a reduction in urinary excre-
tion of purine metabolites during recovery from the sprint.
Materials and methods
Subjects
Seven active, non-specifically trained males (age, 23.1 ±
1.8 y; body mass, 76.1 ± 3.1 kg; VO2 peak, 56.3 ±
4.0 mLkg–1min–1), volunteered for the study, which was
approved by the Victoria University Human Research Ethics
Committee. All subjects were fully informed of the experi-
mental procedures and voluntarily consented to take part in
the study.
Peak oxygen consumption (VO2 peak)
The VO2 peak of each subject was determined approxi-
mately 1 week before the beginning of the experimental tri-
als. The exercise protocol involved riding on a cycle
ergometer (Lode, Groningen, The Netherlands) for 3 min at
3 submaximal work rates, after which the work rate was in-
creased every minute thereafter until volitional exhaustion.
Expired air was directed by a Hans Rudolph valve through
a ventilometer (Pneumoscan S30, KL engineering, Mel-
bourne, Australia) into a mixing chamber and analysed for
oxygen and carbon dioxide content by gas analysers (Ap-
plied Electrochemistry S-3A O2 and CD-3A CO2, Ametek,
Pittsburgh, Penn.). These analysers were calibrated before
each test using commercially prepared gas mixtures. Oxygen
consumption was calculated by a microprocessor using
standard equations.
Sprint testing protocol
Performance tests (PT) were 30 s maximal sprints com-
pleted before and after a training regime. These were per-
formed on an air-braked cycle ergometer, modified to enable
computerized determination of peak power and mean power.
Fatigue index (FI) was calculated using the following equation:
FI ¼ ½ðpeak power  peak power at 30 sÞ
 ðpeak powerÞ1  100
The power output of the air-braked cycle ergometer is ap-
proximately proportional to the cube of the wheel velocity,
which was measured using a tachometer (Hall-effect device
and a cog at the wheel hub). The subjects were instructed to
remain seated and pedal as fast as possible for the 30 s ex-
ercise periods. Subjects were familiarized with the sprint
task at least 1 week prior to the PT. The final PT was per-
formed at least 24 h and less than 36 h after the last training
session. The subjects were also instructed to refrain from
strenuous exercise and caffeine and alcohol consumption
for 24 h before the PT. In addition, subjects recorded their
diet for the 24 h before the first PT and were asked to con-
sume similar foods before the final PT. All PTs were con-
ducted in the morning after an overnight fast. During the
first 15 min of recovery from each PT the subjects ingested
500 mL of water. Subjects were also provided with food
(snack bar, fruit juice, and salad sandwich) after 2 h recov-
ery in each trial and were restricted from any other food in-
take until after an 8 h urine sample was obtained.
Training protocol
Sprint training was performed twice per day for 1 week
and each session was separated by at least 6 h. A training
session involved 15  10 s maximal cycling bouts on an
air-braked cycle ergometer with 50 s of rest between bouts.
Blood and urine sampling, treatment, and analysis
Blood was sampled from an antecubital vein, via an in-
dwelling catheter, at rest, and after 0, 10, 15, 20, 30, 60,
and 120 min of passive recovery from the PT. The blood
was immediately placed into lithium heparin tubes and spun
in a centrifuge. Subsequently, 100 mL of plasma were added
to 200 mL of ice-cold 3 mol/L perchloric acid, spun, and the
supernatant stored at –80 8C before analysis for lactate.
Plasma lactate was determined in duplicate, using an enzy-
matic spectrophotometric technique (Lowry and Passoneau
1972). The remaining plasma was stored in liquid nitrogen
for analysis of inosine, Hx, and uric acid. The plasma stored
for these metabolites was deproteinised with 1.5 mol/L
perchloric acid and subsequently neutralized with 2.1 mol/L
potassium hydrogencarbonate immediately before analysis.
Plasma Hx, inosine, and uric acid were determined on neu-
tralized perchloric acid extracts, using a modification of the
reverse-phase high-performance liquid chromatography
(HPLC) technique described by Wynants and Van Belle
(1985). Separation was achieved using a Merck Hibar Li-
chrosphere 100 CH-18/2 250 mm  4 mm column with the
use of a Waters chromatography workstation.
Urine was collected for 12 h before the PT and for the
first 2, and the subsequent 6 and 16 h periods after the PT.
Urine volume was determined and an aliquot of the samples
was stored at –80 8C before analysis. Samples were depro-
teinised, neutralized, and analyzed for inosine, Hx, and xan-
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thine using the same sample treatment and HPLC proce-
dures as described for plasma. Urinary uric acid concentra-
tion was determined by an enzymatic colorimetric method
using a Beckman Synchron CX1 system. Exercise-induced
endogenous urinary purine excretion was determined by cal-
culating the difference in excretion rate during recovery
from the PT, relative to the pre-PT basal excretion rate.
Muscle sampling treatment and analysis
Muscle biopsies were obtained from the vastus lateralis
under local anasthesia (1% xylocaine) using the percutane-
ous needle biopsy technique. Muscle was sampled from the
same leg from separate incisions at rest, immediately after
exercise, and 10 min into recovery. Leg selection was ran-
dom, with the contralateral leg biopsied in the second PT .
Muscle samples were frozen in liquid nitrogen within 5 s of
obtaining biopsies. Samples were weighed at –30 8C and
freeze-dried, weighed, dissected free of any connective tis-
sue, powdered, and extracted according to the method of
Harris et al. (1974). The neutralized extract was assayed en-
zymatically for phosphocreatine (PCr), creatine (Cr), and
lactate by fluorometric analyses (Lowry and Passoneau
1972). Reverse-phase HPLC was used to quantify ATP,
ADP, AMP, IMP, inosine, and Hx concentrations using the
method of Wynants and Van Belle (1985) with the same ap-
paratus as described for plasma analysis. Muscle ATP, ADP,
AMP, IMP, Cr, and PCr were adjusted to the peak total Cr
content for each subject in each PT for pre- and post-train-
ing trials.
Statistical analysis
All values are reported as means ± SE. Where appropri-
ate, the metabolite and performance data were analysed us-
ing analysis of variance (ANOVA) with repeated measures
(BMDP statistical software). Simple main effects analyses
and Newman–Kuels post hoc tests were used to locate dif-
ferences when ANOVA revealed a significant interaction.
Comparison of performance variables, total Cr content, and
urinary purine loss during recovery were analysed using
paired-sample t tests. The level of probability to reject the
null hypothesis was set at p £ 0.05.
Results
Performance variables
No change in the peak power (1085.1 ± 40.3 W vs.
1081.7 ± 38 W; untrained vs. trained), mean power
(617.9 ± 20.4 W vs. 630.4 ± 10.1 W), or fatigue index
(58.9% ± 1.6% vs. 57.5% ± 1.4%) was observed with sprint
training.
Muscle metabolites
The muscle metabolite contents at rest, immediately after
exercise, and 10 min into recovery are summarized in Ta-
ble 1. No differences were observed with resting muscle me-
tabolites before and after training. The resting ATP levels
showed a tendency to be lower after training using different
analytical methods (p = 0.06 and 0.13, enzymatic and HPLC
methods, respectively). Exercise decreased muscle ATP in
both the pre- and post-training PT, but the levels upon ter-
mination of exercise were significantly higher in the post-
trained compared with the pre-trained state (Table 1). Con-
comitantly, sprint exercise resulted in an accumulation of
IMP and inosine; however, end-exercise IMP and inosine
were lower (p < 0.05) with training (Table 1). The PCr, Cr,
and lactate levels after exercise were unaffected by training.
The ATP content was partially restored 10 min into re-
covery from post-exercise values, but was still lower than
pre-exercise amounts, irrespective of training status. Addi-
tionally, the levels of ATP at 10 min recovery were not dif-
ferent between trials. Similarly, the IMP content reduced
during recovery, but did not return to resting levels in either
trained ot untrained states at 10 min. Muscle inosine contin-
ued to increase during recovery in both trials; however, the
content was lower post-training compared with pre-training
(Table 1). The PCr and Cr levels at 10 min recovery after
training were not different to pre-exercise levels, whereas
they were significantly lower and higher, respectively, than
resting levels in the untrained state. Muscle lactate levels dur-
Table 1. Effect of 7 d of sprint training on skeletal muscle metabolites at rest, after a 30 s sprint, and after 10 min recovery.
Untrained Trained
Rest Exercised 10 min recovery Rest Exercise 10 min recovery
ATP 24.05±1.24 13.35±1.62* 18.70±2.03*,{ 21.16±0.80 16.12±1.56*,{ 19.09±0.85*,{
ATP-HPLC 22.01±1.28 12.49±1.27* 17.47±1.34 19.65±0.80 15.40±1.24*,{ 17.49±0.78*,{
ADP 1.60±0.22 1.57±0.21 1.63±0.26 1.64±0.23 1.70±0.25 1.50±0.23
AMP 0.05±0.01 0.05±0.01 0.05±0.01 0.05±0.01 0.06±0.01 0.05±0.01
IMP 0.04±0.02 7.08±1.19* 3.97±0.37*,{ 0.04±0.02{ 3.06±0.41*,{ 0.42±0.11*,{,{
Inosine 0.01±0.00 0.13±0.02 0.96±0.12*,{ 0.02±0.01 0.06±0.01{ 0.42±0.07*,{,{
Hx <0.01 <0.01 0.04±0.00*,{ <0.01 <0.01 0.03±0.01*,{
PCr 82.0±3.7 27.3±4.4* 71.9±3.8*,{ 87.4±3.7 31.5±4.1* 83.8±4.3{,{
Cr 45.3±3.2 100.1±4.0* 55.5±4.8*,{ 48.4±5.1 104.4±3.3* 52.1±7.0{
Lactate 5.51±0.63 91.90±7.51* 49.37±6.46*,{ 5.53±0.99 83.94±5.32* 39.24±2.53*,{
AdN 23.67±1.34 14.13±1.35* 19.16±1.56*,{ 21.36±0.96 17.17±1.41*,{ 19.05±0.96*,{
AdN + IMP + Inosine 23.72±1.34 21.33±0.61 24.10±1.40 21.41±0.97 20.28±1.21 19.89±0.87
Note: Values are means ± SE; n = 7; units are mmol(kg dry mass)–1.
*Significantly different from rest value at p < 0.05.
{Significantly different from exercise value at p < 0.05.
{Significantly different from untrained value at p< 0.05.
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ing recovery were not affected by training. Muscle ADP and
AMP were not different after PT and 10 min recovery and
were not different across training. Mean total Cr was higher
in the post-trained state (123.1 ± 5.2 vs. 131.5 ± 6.4 mmol(kg
dry mass)–1; p < 0.05, untrained vs. trained, respectively).
Plasma metabolite concentrations
The resting concentration of all measured metabolites
were similar pre- and post-training (Fig. 1). Training re-
sulted in significantly lower levels of inosine in the 15–
30 min (Fig. 1A) and Hx in the 15–60 min (Fig. 1B) period
of recovery, whereas uric acid was lower in the trained state
from 60 min to the end of measurement (120 min; Fig. 1C).
Plasma lactate was not different at any point of time during
recovery in the trained state (data not shown).
Urinary excretion
Urinary excretion of inosine, Hx, and uric acid was ele-
vated during the first 2 h period after exercise. It should be
noted that there was a reduction in inosine excretion in the
trained state compared with the untrained state after 2 h
(Fig. 2A) and a lower uric acid excretion in the 24 h recov-
ery period following PT in the trained state (Fig. 2B). Total
endogenous purine metabolite (inosine + Hx + uric acid) ex-
cretion was not different in the first 2 h (Fig. 2A; 775 ±
133 mmol vs. 739 ± 108 mmol, untrained vs. trained). How-
ever, there was a tendency (p = 0.12) for an attenuated ex-
cretion with training after 8 h recovery, (not shown; 1378 ±
213 mmol vs. 981 ± 141 mmol, respectively) and a reduced
(p < 0.05) excretion in the 24 h recovery period (1603 ±
267 mmol vs. 1237 ± 264 mmol, untrained vs. trained;
Fig. 2B).
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Fig. 1. Forearm venous plasma inosine (A), hypoxanthine (B), and
uric acid (C) concentrations at rest (R) and during recovery from a
30 s sprint bout before and after 1 week of sprint training. Values
are means ± SE, n = 7. Asterisk (*) indicates significant difference
from the untrained state; p < 0.05. (Note difference in scale be-
tween A and B.)
Fig. 2. Exercise endogenous urinary inosine, Hx, uric acid, and to-
tal purine excretion after (A) 2 h and (B) 24 h of recovery from a
30 s sprint bout before and after 1 week of sprint training. Values
are means ± SE, n = 7. Asterisk (*) indicates signicant difference
from the untrained state, p < 0.05.
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Discussion
Sprint training reduced the muscle (Table 1) and plasma
purine concentrations (Fig. 1) and the excretion of urinary
purines during recovery from a 30 s sprint bout (Fig. 2).
This reduction likely represents a training-induced adapta-
tion to minimize the loss of purines from skeletal muscle.
Such an adaptation is advantageous in reducing the subse-
quent metabolic cost of AdN replacement by the purine de
novo biosynthesis pathway.
As expected, sprint training reduced the extent of ATP
degradation (44.6%) and accumulation of IMP and inosine
(56.7% and 66%, respectively) in the muscle during a 30 s
sprint. A similar finding has been reported in other studies
(Stathis et al. 1994; Harmer et al. 2000; Parra et al. 2000)
and demonstrates an improved balance between the rates of
ATP degradation and resynthesis with sprint training. As-
suming any contribution of altered exercise efficiency is
likely minimal, the rate of ATP degradation during the PT is
likely to be the same, as the peak and mean power values
did not differ pre- and post-training. Thus, a more likely
explanation is a training-induced improvement in the re-
phosphorylation rate of ATP, either through anaerobic or
aerobic sources.
The magnitude of PCr degradation during the PT was not
significantly different after training, indicating that it does
not contribute to an enhanced ATP resynthesis rate. Other
contributing factors to ATP resynthesis include anaerobic
glycolysis and oxidative phosphorylation. There is evidence
of increased enzymatic activities of anaerobic glycolysis
(phosphofructokinase and aldolase) with sprint training
(Parra et al. 2000), which could contribute to improved
ADP rephosphorylation. However, the present data indicate
that anaerobic glycolysis was not likely to contribute to the
improved ATP resynthesis rates following sprint training, as
the muscle lactate accumulation (Table 1) and the plasma
lactate recovery profiles were not significantly different
with training (data not shown). An increasing body of evi-
dence suggests there is an increase in the oxidative potential
of skeletal muscle after sprint training (Parra et al. 2000;
Burgomaster et al. 2005). Clearly, no oxygen consumption
or muscle aerobic enzyme activity were measured in the
current study, therefore we are unable to provide any evi-
dence to support the notion that aerobic metabolism was
enhanced in the sprint-trained state. The tempered accumu-
lation of IMP observed during the PT with sprint training
(Table 1) must be due to a reduced flux through AMP de-
aminase (AMPd) or an increased activity of pathways using
IMP. Although it is not clear how the different modulators
influence AMPd during intense exercise, in vitro studies
have demonstrated increases in AMPd activity with elevated
substrate availability (Raggi and Ranieri-Raggi 1987) and
increased concentrations of ADP, AMP, and H+ (Wheeler
and Lowenstein 1979; Lowenstein 1990). Inhibition of
AMPd occurs with elevated orthophosphate, ATP, and gua-
nosine 5’-triphosphate (GTP; Wheeler and Lowenstein 1979;
Lowenstein 1990), hence a reduced net production of AMP
with the aforementioned improvement in the balance be-
tween ATP hydrolysis and ATP resynthesis rates best ex-
plains the reduced IMP accumulation after the sprint
training (Table 1). Other factors that influence AMPd activ-
ity, such as PCr content (Rush et al. 1998), are unlikely to
play a role in the reduced AMPd activity in the trained state,
as the PCr content in mixed muscle was the same at the end
point of exercise in the PT (Table 1). Furthermore, the atte-
nuated accumulation of IMP observed after the PT during
sprint training is not likely due to increased degradation of
IMP to inosine or reamination to AMP via purine nucleotide
activity. A small but significant sprint-trained reduction in
inosine content after the PT (Table 1) indicates that an ele-
vated degradation of IMP to inosine is unlikely. Evidence
from rodent muscle demonstrates that the purine nucleotide
cycle (PNC) does not operate in muscles contracting during
high-intensity exercise (Meyer and Terjung 1980). Further-
more, sprint training attenuated plasma inosine, Hx, and
uric acid concentrations during the first 2 h of recovery after
the sprint (Fig. 2). Lower plasma Hx following training has
been reported in an earlier training study (Stathis et al.
1994) and is best explained by a reduction in the magnitude
of purine efflux from the muscle, although no experimental
evidence is available to confirm this possibility.
Urinary purine excretion in the 24 h after PT was reduced
after sprint training (Fig. 2B) and is best explained by a de-
creased delivery of purine to the kidney due to lower plasma
purine concentration. Attenuated plasma purine is a likely
result of lower muscle purine base production and efflux
into the plasma. The lower urinary purine excretion may
also be influenced by a training-induced change in the loss
of purines via the gut (Sorensen and Levinson 1975). Soren-
sen and Levinson (1975) demonstrated that in normal un-
trained individuals one third of basal uric acid excretion
occurs via the gut and, as yet, no studies have investigated
the influence of intense exercise and (or) sprint training on
this avenue of purine loss.
Previous studies have reported reduced resting muscle
ATP after sprint training (Hellsten-Westing et al. 1993a;
Stathis et al. 1994; Hellsten et al. 2004). A significant reduc-
tion in resting ATP following a similar training protocol to
that used in this study was achieved with 9 (Hellsten-West-
ing et al. 1993a) and 8 (Hellsten et al. 2004) participants.
The current study demonstrates a strong tendency for lower
resting ATP levels in the muscle after sprint training
(Table 1; p = 0.06 and 0.13, enzymatic and HPLC analysis,
respectively). A greater number of participants will be re-
quired to clarify the situation, as the statistical power of the
test for detecting a significant decrease is low in the present
study (i.e., 38%), indicating that a type 2 error is likely. The
imbalance between ATP loss and its resynthesis and (or)
synthesis is considered responsible for the reduction in rest-
ing muscle ATP content. Assuming the elevation in purine
excretion during recovery represents the loss of endogenous
purines from the active muscle, the loss of purine metabo-
lites in 24 h recovery from an intense sprint bout represents
around 2% of the resting ATP content in the untrained and
trained state. This was estimated by calculating the extent of
purine excretion relative to the active muscle. If skeletal
muscle is 40% of body mass (76.1 kg) and the legs comprise
55% of the total muscle mass (Snyder et al. 1975), then the
mean mass of the exercising muscle (both legs) is 3.85 kg
d.m. (assuming 23% dry mass). The urinary purine loss is
probably an underestimate, as uric acid can also cross into
the gut (Sorensen and Levinson 1975). As well as reducing
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the production of purines in the muscle, the conservation of
muscle purine nucleotides with sprint training could also be
enhanced by an increased capacity of intramuscular purine
recovery after sprint training. Evidence of an elevated activ-
ity of the purine salvage enzyme hypoxanthine guanine
phosphoribosyltransferase (HGPRT) after sprint training
(Hellsten-Westing et al. 1993b) supports this possibility and
provides a mechanism to further reduce the loss of purines
from the muscle following exercise in the trained state.
Interestingly, 7 d of intense sprint training resulted in no
differences in mean power, peak power, or the fatigue index
during a 30 s maximal sprint cycle bout. These results are
consistent with those reported after a similar training proto-
col (Hellsten-Westing et al. 1993a). The training protocol
may limit any performance improvement because there is in-
adequate recovery time between sessions to produce optimal
training adaptation. In support of this, Parra et al. (2000)
demonstrated that a training programme using the same
training load, but over a longer duration improved perform-
ance in a 30 s sprint test.
In conclusion, the present study demonstrated that sprint
training reduced purine base accumulation in the muscle
and plasma, and decreased urinary excretion of endogenous
purines (inosine, Hx, and uric acid) after maximal sprint ex-
ercise. An attenuated loss of muscle purine nucleotide deg-
radation products after a sprint bout reduces the extent of
replacement of the muscle nucleotide pool via the metabol-
ically expensive purine de novo synthesis pathway.
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